(Q38046287)

27 August 2017

Entry and replication of recombinant hepatitis C viruses in cell culture (English)

1 reference

27 August 2017

1 reference

Gabrielle Vieyres

1

1 reference

PubMed ID

23009812

27 August 2017

Thomas Pietschmann

series ordinal

2

1 reference

27 August 2017

23 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

59

1 reference

27 August 2017

2

1 reference

27 August 2017

233-248

1 reference

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Evolving epidemiology of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Transmissible agent in non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The hepatitis C virus replicon system: from basic research to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

HCV replicons: overview and basic protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Unravelling hepatitis C virus replication from genome to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Assembly of infectious hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Which in vitro models could be best used to study hepatocyte polarity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Role of lipid metabolism in hepatitis C virus assembly and entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Apolipoprotein E but Not B Is Required for the Formation of Infectious Hepatitis C Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Treatment of chronic hepatitis C infection: one step at a time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Clinical significance of hepatitis C virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Bovine viral diarrhea virus entry is dependent on clathrin-mediated endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of pseudotype VSV possessing HCV envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Studying HCV cell entry with HCV pseudoparticles (HCVpp).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cell culture and infection system for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus: propagation, quantification, and storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Replication and infectivity of a novel genotype 1b hepatitis C virus clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Genotype 1a HCV (H77S) infection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Full-length infectious HCV chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Monitoring the Antiviral Effect of Alpha Interferon on Individual Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A Comprehensive Structure-Function Comparison of Hepatitis C Virus Strain JFH1 and J6 Polymerases Reveals a Key Residue Stimulating Replication in Cell Culture across Genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Use of human hepatocytes to investigate HCV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Microscale culture of human liver cells for drug development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Getting closer to the patient: upgrade of hepatitis C virus infection in primary human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Modeling hepatitis C virus infection using human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Primary hepatocytes as targets for hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Glucocorticosteroids increase cell entry by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Replication of a hepatitis C virus replicon clone in mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Mouse hepatic cells support assembly of infectious hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Genetics of somatic mammalian cells. II. Chromosomal constitution of cells in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Effect of Cell Polarization on Hepatitis C Virus Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A genome-wide genetic screen for host factors required for hepatitis C virus propagation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Dissecting virus entry via endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Screening of small-molecule compounds as inhibitors of HCV entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of functional hepatitis C virus envelope glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Naturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are trans-Packaged In Vitro To Generate Infectious Defective Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Production of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Primary human hepatocyte culture for HCV study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Diverse CD81 Proteins Support Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Rapid synchronization of hepatitis C virus infection by magnetic adsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and Infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Centrifugal enhancement of hepatitis C virus infection of human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Control and regulation of the cellular responses to cold shock: the responses in yeast and mammalian systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A novel small molecule inhibitor of hepatitis C virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Thermal stability and inactivation of hepatitis C virus grown in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Measuring HCV infectivity produced in cell culture and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.09.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMETH.2012.09.005

1 reference

27 August 2017

1 reference

PubMed ID

23009812